We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
14.1
quarters
Top 10 Avg Time Held
19
quarters
Top 20 Avg Time Held
14.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1651
Community Health Systems
CYH
$412M
| $34K | ﹤0.01% |
11,559
+1,536
| +15% | +$4.97K |
2025 Q2
3 quarters
|
|
1652
Allogene Therapeutics
ALLO
$484M
| $33.4K | ﹤0.01% |
13,672
+1,867
| +16% | +$3.74K |
2025 Q2
3 quarters
|
|
1653
Altimmune
ALT
$498M
| $33.2K | ﹤0.01% |
+10,783
| New | +$45.8K |
2026 Q1
0 quarters
|
|
1654
Pacific Biosciences
PACB
$653M
| $32.7K | ﹤0.01% |
24,777
+3,310
| +15% | +$5.92K |
2022 Q2
15 quarters
|
|
1655
Akebia Therapeutics
AKBA
$219M
| $31.7K | ﹤0.01% |
22,782
+2,837
| +14% | +$3.9K |
2024 Q2
7 quarters
|
|
1656
Richtech Robotics
RR
$340M
| $31.1K | ﹤0.01% |
14,867
+3,003
| +25% | +$9.23K |
2025 Q4
1 quarter
|
|
1657
Blend Labs
BLND
$234M
| $30.8K | ﹤0.01% |
18,120
+2,366
| +15% | +$5.06K |
2024 Q2
7 quarters
|
|
1658
Optimum Communications Inc
OPTU
$370M
| $30.6K | ﹤0.01% |
23,569
+3,133
| +15% | +$4.92K |
2025 Q2
3 quarters
|
|
1659
American Battery Technology Co
ABAT
$261M
| $30.3K | ﹤0.01% |
+10,875
| New | +$42K |
2026 Q1
0 quarters
|
|
1660
Cerus
CERS
$455M
| $30.1K | ﹤0.01% |
16,536
+2,214
| +15% | +$4.82K |
2023 Q2
11 quarters
|
|
1661
Real REMAX Group Inc. Common Stock
REAX
$306M
| $30K | ﹤0.01% |
1,201
+169
| +16% | +$5.11K |
2025 Q4
1 quarter
|
|
1662
enCore Energy
EU
$179M
| $29.8K | ﹤0.01% |
16,567
+2,208
| +15% | +$5.64K |
2024 Q2
7 quarters
|
|
1663
Nextdoor Holdings
NXDR
$1B
| $27.5K | ﹤0.01% |
19,671
+2,666
| +16% | +$4.63K |
2024 Q2
7 quarters
|
|
1664
Microvast
MVST
$212M
| $27.2K | ﹤0.01% |
18,120
+2,386
| +15% | +$5.75K |
2025 Q2
3 quarters
|
|
1665
DELISTED
Olaplex Holdings
OLPX
| $26K | ﹤0.01% |
12,804
+1,684
| +15% | +$2.58K |
2025 Q2
3 quarters
|
|
1666
Standard BioTools
LAB
$258M
| $24.9K | ﹤0.01% |
27,043
+3,446
| +15% | +$4.17K |
2024 Q2
7 quarters
|
|
1667
Beyond Meat
BYND
$126M
| $24.5K | ﹤0.01% |
1,164
+168
| +17% | +$4.03K |
2025 Q4
1 quarter
|
|
1668
Evolent Health
EVH
$481M
| $24K | ﹤0.01% |
+10,524
| New | +$33.4K |
2026 Q1
0 quarters
|
|
1669
3D Systems Corp
DDD
$538M
| $23.6K | ﹤0.01% |
+12,545
| New | +$27.9K |
2026 Q1
0 quarters
|
|
1670
Alight
ALIT
$244M
| $23K | ﹤0.01% |
1,975
+261
| +15% | +$6.22K |
2022 Q2
15 quarters
|
|
1671
Ready Capital
RC
$193M
| $22.2K | ﹤0.01% |
13,674
+1,569
| +13% | +$3K |
2024 Q2
7 quarters
|
|
1672
8x8 Inc
EGHT
$295M
| $20K | ﹤0.01% |
12,038
+1,646
| +16% | +$3.37K |
2025 Q2
3 quarters
|
|
1673
Hyliion Holdings
HYLN
$672M
| $19.9K | ﹤0.01% |
+11,303
| New | +$22.7K |
2026 Q1
0 quarters
|
|
1674
EVgo
EVGO
$157M
| $19.8K | ﹤0.01% |
+11,503
| New | +$30.8K |
2026 Q1
0 quarters
|
|
|
SVC
1675
Service Properties Trust
SVC
$768M
| $18.9K | ﹤0.01% |
2,787
+376
| +16% | +$3.91K |
2024 Q2
7 quarters
|
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.